MedTrace Logo

Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction

NCT07173517 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 268

Last updated 2025-09-15

No results posted yet for this study

Summary

Traditional sacral neuromodulation devices are not rechargeable. In recent years, new rechargeable sacral neuromodulation devices have been developed and put into the market. The aim of this study was to evaluate the cost savings of a rechargeable sacral neuromodulation device versus a non-rechargeable sacral neuromodulation device for the treatment of neurogenic lower urinary tract dysfunction.

Conditions

  • Rechargeable Sacral Neuromodulation Device
  • Neurogenic Lower Urinary Tract Dysfunction

Sponsors & Collaborators

  • Aerospace Center Hospital

    collaborator OTHER

  • Shandong Provincial Hospital

    collaborator OTHER_GOV

  • Second Affiliated Hospital of Xi'an Jiaotong University

    collaborator OTHER

  • Beijing Hospital

    collaborator OTHER_GOV

  • Xi'an Honghui Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • Second Hospital of Jilin University

    collaborator OTHER

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    collaborator OTHER

  • Tongji Hospital

    collaborator OTHER

  • Qilu Hospital of Shandong University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07173517 on ClinicalTrials.gov